Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.
about
Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@en
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@nl
type
label
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@en
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@nl
prefLabel
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@en
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@nl
P2093
P2860
P356
P1476
Patient considerations in the ...... roate/umeclidinium/vilanterol.
@en
P2093
Antonio Molino
Giovanna Calabrese
Mauro Maniscalco
P2860
P304
P356
10.2147/PPA.S152179
P407
P577
2018-06-08T00:00:00Z